Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
DNA VACCINES DNA vaccine is DNA sequence used as a vaccine. DNA vaccination is a technique for protecting an organism against disease by injecting it with genetically engineered DNA to produce an immunological response. The direct injection of genetic material into a living host causes a small amount of its cells to produce the introduced gene products. HISTORY The use of genetic material to deliver genes for therapeutic purposes has been practiced for many years. In 1990, University of Wisconsin, Jon Wolff found that injection of DNA plasmids produces a protein response in mice. In 1993, Merck Research Laboratories, Dr. Margaret Liu found that intramuscular injection of DNA from influenza virus into mice produced complete immune response. In 1996, trials involving T-cell lymphoma, influenza & herpes simplex virus were started 4. HOW DNA VACCINES ARE MADE Expression plasmids used in DNA-based vaccination normally contain two units: The antigen expression unit composed of promoter/enhancer sequences, followed by antigen-encoding and polyadenylation sequences and the production unit composed of bacterial sequences necessary for plasmid amplification and selection. The construction of bacterial plasmids with vaccine inserts is accomplished using recombinant DNA technology. Once constructed, the vaccine plasmid is transformed into bacteria, where bacterial growth produces multiple plasmid copies. The plasmid DNA is then purified from the bacteria, by separating the circular plasmid from the much larger bacterial DNA and other bacterial impurities. This purified DNA acts as the vaccine. ADVANTAGES OVER TRADITIONAL VACCINES Subunit vaccination with no risk for infection. Antigen presentation by both MHC class I and class II molecules. Able to polarize T-cell help toward type 1 or type 2. Immune response focused only on antigen of interest. Cost-effectiveness. Long-term persistence of immunogen. DISADVANTAGES Limited to protein immunogens. Risk of affecting genes controlling cell growth. Possibility of inducing antibody production against DNA.